B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
about
B7-H3: a costimulatory molecule for T cell activation and IFN-gamma productionB7-DC, a new dendritic cell molecule with potent costimulatory properties for T cellsB7-H5 costimulates human T cells via CD28HCostimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetNo evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activationSafety, activity, and immune correlates of anti-PD-1 antibody in cancerThe PD-1 pathway in tolerance and autoimmunityConstitutive and inducible expression of b7 family of ligands by human airway epithelial cellsBlockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infectionActive systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) miceMolecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphomaMolecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interactionEngagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationPD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cellsB7x: a widely expressed B7 family member that inhibits T cell activationProgrammed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerCell fate decision: T-helper 1 and 2 subsets in immune responses.Immunologic aspect of ovarian cancer and p53 as tumor antigen.Radiotherapy combination opportunities leveraging immunity for the next oncology practiceMelanoma immunotherapy dominates the fieldA Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune CheckpointsThe efficacy and potential predictive factors of PD-1/PD-L1 blockades in epithelial carcinoma patients: a systematic review and meta analysisThe role of pembrolizumab in the treatment of advanced non-small cell lung cancerLymphocyte-activation gene-3, an important immune checkpoint in cancerImmunotherapy for lung cancerCancer immunotherapy: the beginning of the end of cancer?Immune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumPredictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysisProgrammed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleNovel technologies and emerging biomarkers for personalized cancer immunotherapyA Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All CancersPredictive factors for immunotherapy in melanomaProgrammed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapyHuman Cancer Immunotherapy with PD-1/PD-L1 BlockadeRole of the PD-1 pathway in the immune responseThe programmed death-1 immune-suppressive pathway: barrier to antitumor immunityNew immunotherapies targeting the PD-1 pathwayHerpesvirus exploitation of host immune inhibitory pathwaysTargeted therapies in development for non-small cell lung cancer
P2860
Q24290870-994C81E8-8D72-42B1-9013-7D1D126550AEQ24291070-58FAAD69-4B8C-4635-9FEC-2D6B40FE5E9CQ24295841-D7A14930-756E-4B0B-AEC9-7ACF1A4CD30BQ24559442-0516C47F-A26C-4529-B2E5-0D1ACE094AB3Q24613354-ED710382-EEE8-4713-B437-0CF90A9012B3Q24633070-3BFBB7CD-B39C-47F9-9DF4-37DEBC7AEE15Q24633549-B29E3EAC-D60D-44AE-B243-D6C3A6558F6EQ24645109-66A8CE16-7277-405C-A079-906F4B3994B0Q24652520-D60E46BE-8FAF-44B3-B383-143890E76284Q24655393-78B45462-801B-406A-8BC1-0BE3936009E5Q24670319-6BFB0A78-18F0-488D-9832-7D06D3B101C8Q24672476-849654D4-A31D-4D46-95B7-A5498C734B7DQ24673269-25335011-999F-4799-8BDC-94DC60F9B133Q24675931-C767F2A2-3DB8-4541-97E4-F93AC42B71C3Q24677367-BB65FB56-D987-45CD-BA46-6553486BBB0DQ24683252-2F80F6D5-5C65-49BB-A323-F3EAF8B6B5DAQ24685406-F99A26BA-69C8-45FF-AFA2-D809FEB3807FQ24806926-E6B8B03D-5010-4C99-B207-12EDDCD13263Q24814703-CAE91C17-5024-45E6-9432-F7704F7C5827Q26738443-CA3B786C-02BD-498F-AD54-7006AB561333Q26738671-975D3763-028A-46B9-B06F-F363F14C7421Q26738729-EBC277A7-324E-4370-994E-5F45D2F59A42Q26740280-28CCEA87-B969-46C1-A3A7-6ED28746B8A2Q26744076-A4CB8393-4749-4ED0-8FA4-7244E721B945Q26746209-20804D4D-6200-417F-9E20-3C9DB89E8C0DQ26751254-F6EE8564-A27F-4B65-941D-48C650C9E66AQ26752277-B364227D-7E27-4E65-8BA0-3128DF9399B6Q26765459-0DB1D4FF-0189-42FC-BB24-17256DA66674Q26769728-507E3F0B-4809-481A-BCA6-4F431F8F4347Q26769734-27168BC6-DF79-4799-AD18-1F460E4CA285Q26770780-F56908EB-0251-48A2-B035-3310E6418663Q26777111-5A052423-31C1-455E-9C98-D57943BF8B04Q26778765-0D6F36FB-F986-459F-8F83-E445DF9A5A5BQ26781481-0005E3F4-CDE3-497E-91E0-FB6A0581D85EQ26786108-A76BEA62-9B67-421F-8F29-C7E01EDA69D9Q26828748-B3856291-B00D-4C59-8B1C-0DEC67DA7518Q26829847-337BA3B6-7BCF-4700-A124-4FBAFCA894C6Q27010018-D2D150BC-D02C-4465-B014-07CB0309117BQ27013680-0F5D2448-08AF-488C-A83F-32B35B057EECQ27022852-FFBCD13D-C0CE-48C3-B198-E9A1F096AA8B
P2860
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@ast
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@en
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@en-gb
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@nl
type
label
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@ast
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@en
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@en-gb
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@nl
prefLabel
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@ast
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@en
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@en-gb
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@nl
P2093
P921
P3181
P356
P1433
P1476
B7-H1, a third member of the B ...... n and interleukin-10 secretion
@en
P2093
P2888
P304
P3181
P356
10.1038/70932
P407
P577
1999-12-01T00:00:00Z
P6179
1005008226